The design of therapeutic antibodies has long been a cornerstone of modern biopharmaceutical innovation. Yet traditional discovery pipelines—reliant on animal immunization, patient-derived antibodies, and wet-lab optimization—are inherently slow, costly, and difficult toRead More…